Close Menu
Gun and TacticalGun and Tactical
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Facebook X (Twitter) Instagram
Gun and TacticalGun and Tactical
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Subscribe
Gun and TacticalGun and Tactical
  • News
  • Guns and Gear
  • Prepping & Survival
  • Tactical
  • Videos
Home » Russia’s Cancer Vaccine Administered To Melanoma Patient
Prepping & Survival

Russia’s Cancer Vaccine Administered To Melanoma Patient

David LuttrellBy David LuttrellApril 2, 20262 Mins Read
Facebook Twitter Pinterest WhatsApp Telegram Email LinkedIn Tumblr
Russia’s Cancer Vaccine Administered To Melanoma Patient

The Russian Ministry of Health announced yesterday that doctors at the National Medical Research Center for Radiology administered the country’s first domestically developed personalized mRNA-based cancer vaccine. The patient who received the vaccine is a 60-year-old melanoma patient.

Neooncovac, is the first domestically developed personalized mRNA-based cancer vaccine.

First Test Batches of Russia’s AI-assisted Cancer Vaccine Have Been Created

According to Doolly, his therapeutic vaccine, created using the patient’s unique tumor-specific mutations and molecular-genetic characteristics, works as an individualized anti-tumor treatment by encoding neoantigens into mRNA delivered via lipid nanoparticles. It trains the immune system to mount a targeted T-cell response against cancer cells while aiming to minimize harm to healthy tissue.

Neooncovac is authorized for adult patients with inoperable or metastatic cutaneous melanoma, often alongside immunotherapy.

Other countries have been looking into using artificial intelligence in order to create and test cancer vaccines.

UK Will Be The First to Trial BioNTech’s mRNA Cancer “Vaccines.”

mRNA “Vaccines” Facing Backlash?

Personalized cancer vaccines differ fundamentally from conventional preventive vaccines. They serve as therapeutic vaccines designed to treat existing disease by harnessing the patient’s immune system. The approach relies on identifying neoantigens—unique proteins generated by tumor-specific mutations present only in cancer cells. –Doolly

After the injection, the mRNA in the vaccine instructs the patient’s cells to produce neoantigens, then presents them to the immune system. This stimulates a targeted T-cell response and broader immune response, training the body to recognize and eliminate cancer cells bearing the same mutations. Because the vaccine focuses on patient-specific alterations, it aims to minimize effects on healthy tissue while potentially creating long-term immune memory against recurrence.

Russian researchers built on expertise gained from prior mRNA work, including platforms developed during the COVID-19 response.

Who Is At Fault When Americans Distrust COVID “Vaccines?” Russia, Of Course!

Many still don’t trust mRNA vaccines after the rushed COVID-19 injections were all but forced on the public. Perhaps if the science goes in a more favorable direction, people will start to actually trust thsoe who are right now, only making money off of ailments and sicknesses.

Read the full article here
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Native, Pioneer, And Amish Responses To Crop Failure In The First 72 Hours – Survivopedia

A Skeptical Guide to UBI

Trump and Fauci: The Nefarious Tag Team Executing the Genetic Kill Switch on Humanity

Trump’s Approval Tanks

BMW Plans To Cut 8,000 Jobs By Late 2027

Quick Return To WAR: US Responds To Iran’s “Surprise Attack” With Bombings

Editor's Picks

Clay Travis pledges $10M for ‘battle of the sexes’ matchup as WNBA trans debate intensifies

August 3, 2026

Army approves service-wide wear of Jungle Tab

August 3, 2026

Living longer could hinge on one surprising dietary change, study review suggests

August 3, 2026

US Coast Guard had 14 suicides in 2024, the highest in a decade

August 3, 2026

Notre Dame caves, lives up to Marcus Freeman’s promise as USC rivalry game is officially back

August 3, 2026

Type above and press Enter to search. Press Esc to cancel.